![Robert Hoffman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Hoffman
Directeur Financier/CFO chez
CYTODYN INC.
Fortune : 275 193 $ au 31/05/2026
Profil
Robert E.
Hoffman currently works at Day For Change, as Director, FibroBiologics, Inc., as Independent Director from 2025, TuHURA Biosciences, Inc., as Director from 2024, Esperion Therapeutics, Inc., as Independent Director from 2025, and CytoDyn, Inc., as Chief Financial & Accounting Officer from 2025.
Mr. Hoffman also formerly worked at Kintara Therapeutics, Inc., as Chairman, President, Chief Executive Officer & CFO from 2023 to 2024, Antibe Therapeutics, Inc., as Chairman from 2022 to 2024, Telik, Inc., as Director, CombiMatrix Corp., as Independent Director from 2013 to 2017, Zeta Acquisition Corp.
III, as Director, Kura Oncology, Inc., as Independent Director from 2015 to 2021, Aslan Pharmaceuticals Ltd., as Independent Non-Executive Director, Versartis, Inc., as Independent Director, Financial Executives International of San Diego Chapter, as President & Director from 2010 to 2020, Saniona AB, as Independent Director from 2021 to 2022, MabVax Therapeutics Holdings, Inc., as Independent Director from 2014 to 2017, Aravive, Inc., as Independent Director from 2018 to 2020, ASLAN Pharmaceuticals Pte Ltd., as Independent Director, Heron Therapeutics, Inc., as Chief Financial Officer & Senior VP-Finance from 2017 to 2020, Document Sciences Corp., as Assistant Controller from 1994 to 1997, Arena Pharmaceuticals, Inc., as Chief Financial Officer & Senior VP-Finance from 2012 to 2015, AnaptysBio, Inc., as Chief Financial Officer from 2015 to 2016, Innovus Pharmaceuticals, Inc., as Chief Financial & Accounting Officer, Executive VP from 2016 to 2017, Polaris Group, Inc., as Chief Financial Officer in 2011, and Arena Pharmaceuticals, Inc., as Chief Financial Officer & Senior VP-Finance.
Mr. Hoffman received his undergraduate degree in 1988 from St. Bonaventure University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 85 153 ( 0,03% ) | 266 529 $ | 31/05/2026 | |
0,01% | 30/04/2026 | 3 641 ( 0,01% ) | 8 229 $ | 31/05/2026 |
FIBROBIOLOGICS, INC. 0,01% | 24/04/2026 | 375 ( 0,01% ) | 435 $ | 31/05/2026 |
Postes actifs de Robert Hoffman
| Sociétés | Poste | Début |
|---|---|---|
| FIBROBIOLOGICS, INC. | Directeur/Membre du Conseil | 08/04/2021 |
| ESPERION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2025 |
| CYTODYN INC. | Directeur Financier/CFO | 15/05/2025 |
Day For Change
 Day For Change Miscellaneous Commercial ServicesCommercial Services Day For Change is a 501(c)(3) nonprofit organization that works to improve the lives of abused, neglected, and disadvantaged children in the community. The private company is based in San Diego, CA. The board of directors reviews grant applications to ensure alignment with its mission and effective use of funds. The organization directs all raised funds to local charities and encourages collaboration among individuals, businesses, and foundations to address challenges such as homelessness, child abuse, poverty, and child sex trafficking. Founded by financial management professionals, it donates funds to local nonprofits, focusing on smaller, underfunded organizations that provide crisis intervention, foster care, mentoring, mental health services, and other support programs. | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert Hoffman
| Sociétés | Poste | Fin |
|---|---|---|
| KINTARA THERAPEUTICS, INC. | Directeur Général | 01/10/2024 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets | Directeur/Membre du Conseil | 17/07/2024 |
| ANTIBE THERAPEUTICS INC. | Président | 24/04/2024 |
| SANA AB | Directeur/Membre du Conseil | 25/05/2022 |
| KURA ONCOLOGY, INC. | Directeur/Membre du Conseil | 03/08/2021 |
Formation de Robert Hoffman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Document Sciences Corp.
 Document Sciences Corp. Packaged SoftwareTechnology Services Develops software for customer communications management solutions | Technology Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
CombiMatrix Corp.
 CombiMatrix Corp. Medical/Nursing ServicesHealth Services Provides molecular diagnostic services | Health Services |
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Innovus Pharmaceuticals, Inc.
 Innovus Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Engages in commercialization, licensing and development of medicine and consumer care products | Health Technology |
Zeta Acquisition Corp. III
 Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Miscellaneous |
Kintara Therapeutics, Inc.
 Kintara Therapeutics, Inc. BiotechnologyHealth Technology Develops novel cancer therapies | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
St. Bonaventure University
 St. Bonaventure University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaris Group, Inc.
 Polaris Group, Inc. Real Estate DevelopmentFinance Offers real estate sales, marketing & consulting services | Finance |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Antibe Therapeutics, Inc.
 Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets | Health Technology |
Financial Executives International of San Diego Chapter
 Financial Executives International of San Diego Chapter Financial Executives International of San Diego Chapter is a company based in La Jolla, CA. | |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes immunotherapeutics for the treatment of cancer | Health Technology |
Aslan Pharmaceuticals Ltd.
 Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
Day For Change
Day For Change Miscellaneous Commercial ServicesCommercial Services Day For Change is a 501(c)(3) nonprofit organization that works to improve the lives of abused, neglected, and disadvantaged children in the community. The private company is based in San Diego, CA. The board of directors reviews grant applications to ensure alignment with its mission and effective use of funds. The organization directs all raised funds to local charities and encourages collaboration among individuals, businesses, and foundations to address challenges such as homelessness, child abuse, poverty, and child sex trafficking. Founded by financial management professionals, it donates funds to local nonprofits, focusing on smaller, underfunded organizations that provide crisis intervention, foster care, mentoring, mental health services, and other support programs. | Commercial Services |
FibroBiologics, Inc.
 FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
